Skip to ContentSkip to Navigation
About us Latest news News News articles

Erythropoietin in heart failure. Effects beyond erythropoiesis

12 January 2011

PhD ceremony: Mr. W.T. Ruifrok, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen

Title: Erythropoietin in heart failure. Effects beyond erythropoiesis

Promotor(s): prof. W.H. van Gilst, prof. D.J. van Veldhuisen

Faculty: Medical Sciences

 

Heart failure is a serious disease with a poor prognosis, often occurring with co-morbidity including anemia. The focus of this study was to unravel the mechanisms of erythropoietin (EPO) in heart failure. The general outcome of the study is that the positive effects of EPO in heart failure are related to other mechanisms than its role in the formation of red blood cells.

 

Last modified:13 March 2020 01.12 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.